US Patent Issued to UNIVERSITY OF MARYLAND, BALTIMORE on Feb. 3 for "Methods of treating cancer by targeting ZSCAN4 activity in cancer stem cells" (Maryland Inventors)

ALEXANDRIA, Va., Feb. 3 -- United States Patent no. 12,540,173, issued on Feb. 3, was assigned to UNIVERSITY OF MARYLAND, BALTIMORE (Baltimore).

"Methods of treating cancer by targeting ZSCAN4 activity in cancer stem cells" was invented by Michal Zalzman (Baltimore) and Benjamin Portney (Baltimore).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are methods of treating cancer in a subject, comprising administering to the subject a therapeutically effective amount of an agent that inhibits the activity of ZSCAN4 in cancer cells in the subject, thereby treating the cancer."

The patent was filed on May 22, 2020, under Application No. 17/613,443.

*For further information, including images, charts...